![Kin Yip Leung](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kin Yip Leung
Directeur/Bestuurslid bij
NOVOCURE LIMITED
Vermogen: 2 M $ op 30-06-2026
Profiel
Kin Yip Leung is currently an Independent Director at NovoCure Ltd. since 2011.
Former roles include Independent Director at Curia Global, Inc. from 2010 to 2016; Director at Delcath Systems, Inc. in 2014; Director at NanoMed Pharmaceuticals, Inc.; Independent Non-Executive Director at Pernix Therapeutics Holdings, Inc. from 2016 to 2019; Principal at Bristol Myers Squibb Co. from 1990 to 1999; EVP, President-Oncology & Diabetes Business at OSI Pharmaceuticals, Inc. from 2003 to 2010; Group Vice President-Global Prescription Business at Pharmacia Corp.
from 1999 to 2003; and Member at C-Change.
Education includes undergraduate studies at The University of Texas at Austin and graduate studies at the University of Wisconsin.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
NOVOCURE LTD. 0,09% | 03-06-2026 | 101.109 ( 0,09% ) | 2 M $ | 30-06-2026 |
Actieve functies van Kin Yip Leung
| Bedrijven | Functie | Begin |
|---|---|---|
| NOVOCURE LIMITED | Directeur/Bestuurslid | 05-08-2011 |
Eerdere bekende functies van Kin Yip Leung
| Bedrijven | Functie | Einde |
|---|---|---|
| PERNIX THERAPEUTICS HOLDINGS INC | Directeur/Bestuurslid | 09-05-2019 |
| ALBANY MOLECULAR RESEARCH, INC. | Directeur/Bestuurslid | 04-02-2016 |
| DELCATH SYSTEMS, INC. | Voorzitter | 15-09-2014 |
| OSI PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-01-2010 |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Corporate Officer/Principal | 01-04-2003 |
Opleiding van Kin Yip Leung
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
80
Eerstegraads connecties
11
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 11 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical drugs | Health Technology |
Curia Global, Inc.
 Curia Global, Inc. BiotechnologyHealth Technology Operates as a global contract research and manufacturing company that provides drug discovery, development & production services | Health Technology |
Delcath Systems, Inc.
 Delcath Systems, Inc. Medical SpecialtiesHealth Technology Develops and manufactures drugs for treatment of cancer | Health Technology |
NanoMed Pharmaceuticals, Inc.
 NanoMed Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic and diagnostic products | Commercial Services |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Health Technology |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
C-Change
 C-Change Other Consumer ServicesConsumer Services C-Change is a private company based in Washington, DC. C-Change was founded by Kevin Sharps, Lynn L. Davison. | Consumer Services |
NovoCure Ltd.
 NovoCure Ltd. Medical SpecialtiesHealth Technology Operates as a commercial-stage oncology company | Health Technology |
Pernix Therapeutics Holdings, Inc.
 Pernix Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Health Technology |
